Free Content Pulmonary administration of aerosolised fentanyl: pharmacokinetic analysis of systemic delivery

Authors: Mather L.E.1; Woodhouse A.1; Ward M.E.1; Farr S.J.2; Rubsamen R.A.2; Eltherington L.G.2

Source: British Journal of Clinical Pharmacology, Volume 46, Number 1, July 1998 , pp. 37-43(7)

Publisher: Blackwell Publishing

Key:
Free Content - Free Content
New Content - New Content
Subscribed Content - Subscribed Content
Free Trial Content - Free Trial Content

Abstract:

Aims Pulmonary drug delivery is a promising noninvasive method of systemic administration. Our aim was to determine whether a novel breath-actuated, microprocessor-controlled metered dose oral inhaler (SmartMistTM, Aradigm Corporation) could deliver fentanyl in a way suitable for control of severe pain.

Methods Aersolised pulmonary fentanyl base 100–300 mgrg was administered to healthy volunteers using SmartMistTM and the resultant plasma concentration-time data were compared with those from the same doses administered by intravenous (i.v.) injection in the same subjects.

Results Plasma concentrations from SmartMistTM were similar to those from i.v. injection. Time-averaged bioavailability based upon nominal doses averaged 100%, and was >50% within 5 min of delivery. Fentanyl systemic pharmacokinetics were similar to those previously reported with no trends to dose-dependence from either route. Side-effects (e.g. sedation, lightheadedness) were the same from both routes.

Conclusions Fentanyl delivery using SmartMistTM can provide analgetically relevant plasma drug concentrations. This, combined with its ease of noninvasive use and transportability, suggests a strong potential for field and domicilliary use, and for patient controlled analgesia without the need for i.v. cannulae.

Keywords: bioavailability; fentanyl; pharmacokinetics; pulmonary administration

Document Type: Research article

DOI: 10.1046/j.1365-2125.1998.00035.x

Affiliations: 1: Department of Anaesthesia and Pain Management, University of Sydney at Royal North Shore Hospital, St Leonards, NSW 2065, Australia, 2: Aradigm Corporation, 26219 Eden Landing Road, Hayward, CA 94545, USA

You have access to the full text article on a website external to Ingentaconnect.

Please click here to view this article on InterScience.

You may be required to register and activate access on InterScience before you can obtain the full text. If you have any queries please contact onlinehelp@oxon.blackwellpublishing.com

Back to top

Key:
Free Content - Free Content
New Content - New Content
Subscribed Content - Subscribed Content
Free Trial Content - Free Trial Content
Share this item with others: These icons link to social bookmarking sites where readers can share and discover new web pages.
Page Help Click here for Page Help
Shopping cart
Tools
Sign in






Need to register?
Sign up here
Text size: A | A | A | A